{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:38:44Z","timestamp":1788431924914,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11060-024-04833-w","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T06:06:24Z","timestamp":1732773984000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ends of the spectrum best practices for early detection and multidisciplinary management of acromegaly"],"prefix":"10.1007","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1797-1124","authenticated-orcid":false,"given":"Stephanie Kim","family":"Cheok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samon","family":"Tavakoli-Sabour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Zwagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Ioachimescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"11","key":"4833_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11):804\u2013826. https:\/\/doi.org\/10.1016\/S2213-8587(22)00244-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4833_CR2","doi-asserted-by":"crossref","unstructured":"Lavrentaki, A., Paluzzi, A., Wass, J.A. and Karavitaki, N., 2017. Epidemiology of acromegaly: review of population studies. Pituitary, 20, pp.4\u20139","DOI":"10.1007\/s11102-016-0754-x"},{"issue":"3","key":"4833_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The Epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49(3):347\u2013355. https:\/\/doi.org\/10.1016\/j.ecl.2020.04.002","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"4833_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/cen.14392","volume":"94","author":"J Dal","year":"2021","unstructured":"Dal J, Skov BG, Andersen M et al (2021) Sex differences in acromegaly at diagnosis: a nationwide cohort study and meta-analysis of the literature. Clin Endocrinol (Oxf) 94(4):625\u2013635. https:\/\/doi.org\/10.1111\/cen.14392","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"4833_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/cen.14828","volume":"97","author":"C Aagaard","year":"2022","unstructured":"Aagaard C, Christophersen AS, Finnerup S et al (2022) The prevalence of acromegaly is higher than previously reported: changes over a three-decade period. Clin Endocrinol (Oxf) 97(6):773\u2013782. https:\/\/doi.org\/10.1111\/cen.14828","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"4833_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/13696998.2021.1898968","volume":"24","author":"A Ribeiro-Oliveira Jr","year":"2021","unstructured":"Ribeiro-Oliveira A Jr, Brook RA, Munoz KA et al (2021) Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care. J Med Econ Jan-Dec 24(1):432\u2013439. https:\/\/doi.org\/10.1080\/13696998.2021.1898968","journal-title":"J Med Econ Jan-Dec"},{"key":"4833_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2021.101389","volume":"59","author":"MD Whittington","year":"2021","unstructured":"Whittington MD, Munoz KA, Whalen JD, Ribeiro-Oliveira A, Campbell JD (2021) Economic and clinical burden of comorbidities among patients with acromegaly. Growth Horm IGF Res 59:101389. https:\/\/doi.org\/10.1016\/j.ghir.2021.101389","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"4833_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182(6):523\u2013531. https:\/\/doi.org\/10.1530\/EJE-20-0019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"4833_CR9","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvad097","volume":"189","author":"S Stormann","year":"2023","unstructured":"Stormann S, Cuny T (2023) The socioeconomic burden of acromegaly. Eur J Endocrinol 189(2):R1\u2013R10. https:\/\/doi.org\/10.1093\/ejendo\/lvad097","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"4833_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ecl.2020.05.010","volume":"49","author":"S Frara","year":"2020","unstructured":"Frara S, Rodriguez-Carnero G, Formenti AM, Martinez-Olmos MA, Giustina A, Casanueva FF (2020) Pituitary tumors centers of excellence. Endocrinol Metab Clin North Am 49(3):553\u2013564. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"4833_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","volume":"20","author":"L Vilar","year":"2017","unstructured":"Vilar L, Vilar CF, Lyra R, Lyra R, Naves LA (2017) Acromegaly: clinical features at diagnosis. Pituitary 20(1):22\u201332. https:\/\/doi.org\/10.1007\/s11102-016-0772-8","journal-title":"Pituitary"},{"issue":"4","key":"4833_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/MED.0000000000000650","volume":"28","author":"AG Ioachimescu","year":"2021","unstructured":"Ioachimescu AG (2021) Acromegaly: achieving timely diagnosis and improving outcomes by personalized care. Curr Opin Endocrinol Diabetes Obes 28(4):419\u2013426. https:\/\/doi.org\/10.1097\/MED.0000000000000650","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"4833_CR13","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2010.7.FOCUS10169","volume":"29","author":"MB Lopes","year":"2010","unstructured":"Lopes MB (2010) Growth hormone-secreting adenomas: pathology and cell biology. Neurosurg Focus 29(4):E2. https:\/\/doi.org\/10.3171\/2010.7.FOCUS10169","journal-title":"Neurosurg Focus"},{"issue":"3","key":"4833_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A et al (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3):294\u2013302. https:\/\/doi.org\/10.1007\/s11102-012-0420-x","journal-title":"Pituitary"},{"issue":"1","key":"4833_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322. https:\/\/doi.org\/10.1007\/s11102-023-01360-1","journal-title":"Pituitary"},{"key":"4833_CR16","doi-asserted-by":"publisher","first-page":"e843","DOI":"10.1016\/j.wneu.2021.11.079","volume":"158","author":"G Watanabe","year":"2022","unstructured":"Watanabe G, Choi SY, Adamson DC (2022) Pituitary incidentalomas in the United States: a national database estimate. World Neurosurg 158:e843\u2013e855. https:\/\/doi.org\/10.1016\/j.wneu.2021.11.079","journal-title":"World Neurosurg"},{"issue":"4","key":"4833_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"PU Freda","year":"2011","unstructured":"Freda PU, Beckers AM, Katznelson L et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894\u2013904. https:\/\/doi.org\/10.1210\/jc.2010-1048","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4833_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1210\/clinem\/dgaa750","volume":"106","author":"X Guo","year":"2021","unstructured":"Guo X, Wang K, Yu S et al (2021) Quality of life and its determinants in patients with treated acromegaly: a cross-sectional nationwide study in China. J Clin Endocrinol Metab 106(1):211\u2013225. https:\/\/doi.org\/10.1210\/clinem\/dgaa750","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4833_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/jendso\/bvab176","volume":"6","author":"AG Ioachimescu","year":"2022","unstructured":"Ioachimescu AG, Goswami N, Handa T, Pappy A, Veledar E, Oyesiku NM (2022) Racial disparities in acromegaly and cushing\u2019s disease: a referral center study in 241 patients. J Endocr Soc 6(1):176. https:\/\/doi.org\/10.1210\/jendso\/bvab176","journal-title":"J Endocr Soc"},{"issue":"2","key":"4833_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12020-019-02123-4","volume":"67","author":"AG Ioachimescu","year":"2020","unstructured":"Ioachimescu AG, Handa T, Goswami N, Pappy AL 2nd, Veledar E, Oyesiku NM (2020) Gender differences and temporal trends over two decades in acromegaly: a single center study in 112 patients. Endocrine 67(2):423\u2013432. https:\/\/doi.org\/10.1007\/s12020-019-02123-4","journal-title":"Endocrine"},{"issue":"11","key":"4833_CR21","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4833_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11102-023-01322-7","volume":"26","author":"TNA Slagboom","year":"2023","unstructured":"Slagboom TNA, van Bunderen CC, De Vries R, Bisschop PH, Drent ML (2023) Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines. Pituitary 26(4):319\u2013332. https:\/\/doi.org\/10.1007\/s11102-023-01322-7","journal-title":"Pituitary"},{"key":"4833_CR23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkan A, Beckers A et al (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz096","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"4833_CR24","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1210\/clinem\/dgac400","volume":"107","author":"D Esposito","year":"2022","unstructured":"Esposito D, Olsson DS, Franzen S et al (2022) Effect of diabetes on morbidity and mortality in patients with acromegaly. J Clin Endocrinol Metab 107(9):2483\u20132492. https:\/\/doi.org\/10.1210\/clinem\/dgac400","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4833_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","volume":"24","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Biller BMK, Freda PU et al (2021) A pituitary society update to acromegaly management guidelines. Pituitary 24(1):1\u201313. https:\/\/doi.org\/10.1007\/s11102-020-01091-7","journal-title":"Pituitary"},{"issue":"3\u20134","key":"4833_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ando.2020.03.010","volume":"82","author":"P Kamenicky","year":"2021","unstructured":"Kamenicky P, Maione L, Chanson P (2021) Cardiovascular complications of acromegaly. Ann Endocrinol (Paris) 82(3\u20134):206\u2013209. https:\/\/doi.org\/10.1016\/j.ando.2020.03.010","journal-title":"Ann Endocrinol (Paris)"},{"issue":"5","key":"4833_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00005792-199409000-00001","volume":"73","author":"S Ezzat","year":"1994","unstructured":"Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG (1994) Acromegaly. clinical and biochemical features in 500 patients. Med (Baltimore) 73(5):233\u2013240","journal-title":"Med (Baltimore)"},{"issue":"4","key":"4833_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11102-016-0725-2","volume":"19","author":"A Abreu","year":"2016","unstructured":"Abreu A, Tovar AP, Castellanos R et al (2016) Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary 19(4):448\u2013457. https:\/\/doi.org\/10.1007\/s11102-016-0725-2","journal-title":"Pituitary"},{"issue":"6","key":"4833_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/cen.12314","volume":"79","author":"I Kreitschmann-Andermahr","year":"2013","unstructured":"Kreitschmann-Andermahr I, Siegel S, Weber Carneiro R, Maubach JM, Harbeck B, Brabant G (2013) Headache and pituitary disease: a systematic review. Clin Endocrinol (Oxf) 79(6):760\u2013769. https:\/\/doi.org\/10.1111\/cen.12314","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"4833_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10194-008-0084-0","volume":"10","author":"JA Gondim","year":"2009","unstructured":"Gondim JA, de Almeida JP, de Albuquerque LA, Schops M, Gomes E, Ferraz T (2009) Headache associated with pituitary tumors. J Headache Pain 10(1):15\u201320. https:\/\/doi.org\/10.1007\/s10194-008-0084-0","journal-title":"J Headache Pain"},{"issue":"2","key":"4833_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11102-017-0854-2","volume":"21","author":"DL Penn","year":"2018","unstructured":"Penn DL, Burke WT, Laws ER (2018) Management of non-functioning pituitary adenomas: surgery. Pituitary 21(2):145\u2013153. https:\/\/doi.org\/10.1007\/s11102-017-0854-2","journal-title":"Pituitary"},{"issue":"Pt 8","key":"4833_CR32","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/brain\/awh525","volume":"128","author":"MJ Levy","year":"2005","unstructured":"Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ (2005) The clinical characteristics of headache in patients with pituitary tumours. Brain 128(Pt 8):1921\u20131930. https:\/\/doi.org\/10.1093\/brain\/awh525","journal-title":"Brain"},{"issue":"2","key":"4833_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/a:1009980404404","volume":"1","author":"I Lancranjan","year":"1999","unstructured":"Lancranjan I, Atkinson AB (1999) Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group Pituitary 1(2):105\u2013114. https:\/\/doi.org\/10.1023\/a:1009980404404","journal-title":"Sandostatin LAR Group Pituitary"},{"issue":"10","key":"4833_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1055\/s-2001-17910","volume":"33","author":"S Cannavo","year":"2001","unstructured":"Cannavo S, Squadrito S, Curto L, Almoto B, Trimarchi F (2001) Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma. Horm Metab Res 33(10):618\u2013624. https:\/\/doi.org\/10.1055\/s-2001-17910","journal-title":"Horm Metab Res"},{"issue":"4","key":"4833_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1468-2982.1994.1404303.x","volume":"14","author":"A May","year":"1994","unstructured":"May A, Lederbogen S, Diener HC (1994) Octreotide dependency and headache: a case report. Cephalalgia 14(4):303\u2013304. https:\/\/doi.org\/10.1046\/j.1468-2982.1994.1404303.x","journal-title":"Cephalalgia"},{"issue":"2","key":"4833_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/EJE-20-0530","volume":"184","author":"K Vouzouneraki","year":"2021","unstructured":"Vouzouneraki K, Esposito D, Mukka S et al (2021) Carpal tunnel syndrome in acromegaly: a nationwide study. Eur J Endocrinol 184(2):209\u2013216. https:\/\/doi.org\/10.1530\/EJE-20-0530","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4833_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11102-016-0765-7","volume":"20","author":"M Buchfelder","year":"2017","unstructured":"Buchfelder M, Schlaffer SM (2017) The surgical treatment of acromegaly. Pituitary 20(1):76\u201383. https:\/\/doi.org\/10.1007\/s11102-016-0765-7","journal-title":"Pituitary"},{"issue":"5","key":"4833_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11102-017-0813-y","volume":"20","author":"C Fernandez Mateos","year":"2017","unstructured":"Fernandez Mateos C, Garcia-Uria M, Morante TL, Garcia-Uria J (2017) Acromegaly: surgical results in 548 patients. Pituitary 20(5):522\u2013528. https:\/\/doi.org\/10.1007\/s11102-017-0813-y","journal-title":"Pituitary"},{"key":"4833_CR39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.wneu.2017.04.141","volume":"104","author":"JH Kim","year":"2017","unstructured":"Kim JH, Hur KY, Lee JH et al (2017) Outcome of endoscopic transsphenoidal surgery for acromegaly. World Neurosurg 104:272\u2013278. https:\/\/doi.org\/10.1016\/j.wneu.2017.04.141","journal-title":"World Neurosurg"},{"key":"4833_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.743052","volume":"12","author":"T Cardinal","year":"2021","unstructured":"Cardinal T, Collet C, Wedemeyer M et al (2021) Postoperative GH and degree of reduction in IGF-1 predicts postoperative hormonal remission in acromegaly. Front Endocrinol (Lausanne) 12:743052. https:\/\/doi.org\/10.3389\/fendo.2021.743052","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"4833_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3171\/2013.8.JNS13224","volume":"119","author":"DB Hazer","year":"2013","unstructured":"Hazer DB, Isik S, Berker D et al (2013) Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. J Neurosurg 119(6):1467\u20131477. https:\/\/doi.org\/10.3171\/2013.8.JNS13224","journal-title":"J Neurosurg"},{"issue":"5","key":"4833_CR42","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1227\/NEU.0b013e31823f5c16","volume":"70","author":"EH Kim","year":"2012","unstructured":"Kim EH, Oh MC, Lee EJ, Kim SH (2012) Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Neurosurgery 70(5):1106\u20131113. https:\/\/doi.org\/10.1227\/NEU.0b013e31823f5c16","journal-title":"Neurosurgery"},{"issue":"5","key":"4833_CR43","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s11102-020-01063-x","volume":"23","author":"N Agrawal","year":"2020","unstructured":"Agrawal N, Ioachimescu AG (2020) Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review. Pituitary 23(5):582\u2013594. https:\/\/doi.org\/10.1007\/s11102-020-01063-x","journal-title":"Pituitary"},{"issue":"9","key":"4833_CR44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P et al (2018) A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552\u2013561. https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"4833_CR45","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s11102-016-0734-1","volume":"19","author":"JM Silverstein","year":"2016","unstructured":"Silverstein JM (2016) Hyperglycemia induced by pasireotide in patients with Cushing\u2019s disease or acromegaly. Pituitary 19(5):536\u2013543. https:\/\/doi.org\/10.1007\/s11102-016-0734-1","journal-title":"Pituitary"},{"issue":"1","key":"4833_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11102-016-0783-5","volume":"20","author":"ML Gheorghiu","year":"2017","unstructured":"Gheorghiu ML (2017) Updates in outcomes of stereotactic radiation therapy in acromegaly. Pituitary 20(1):154\u2013168. https:\/\/doi.org\/10.1007\/s11102-016-0783-5","journal-title":"Pituitary"},{"issue":"6","key":"4833_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101713","volume":"36","author":"A McCormack","year":"2022","unstructured":"McCormack A (2022) Temozolomide in aggressive pituitary tumours and pituitary carcinomas. Best Pract Res Clin Endocrinol Metab 36(6):101713. https:\/\/doi.org\/10.1016\/j.beem.2022.101713","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"4833_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","volume":"24","author":"MR Gadelha","year":"2013","unstructured":"Gadelha MR, Kasuki L, Korbonits M (2013) Novel pathway for somatostatin analogs in patients with acromegaly. Trends Endocrinol Metab 24(5):238\u2013246. https:\/\/doi.org\/10.1016\/j.tem.2012.11.007","journal-title":"Trends Endocrinol Metab"},{"key":"4833_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.846614","volume":"12","author":"X Liu","year":"2022","unstructured":"Liu X, Dai C, Bao X et al (2022) The Clinical and pathological characteristics of refractory pituitary adenomas: a single center experience. Front Oncol 12:846614. https:\/\/doi.org\/10.3389\/fonc.2022.846614","journal-title":"Front Oncol"},{"key":"4833_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.700007","volume":"12","author":"M Luo","year":"2021","unstructured":"Luo M, Tan Y, Chen W et al (2021) Clinical efficacy of temozolomide and its predictors in aggressive pituitary tumors and pituitary carcinomas: a systematic review and meta-analysis. Front Neurol 12:700007. https:\/\/doi.org\/10.3389\/fneur.2021.700007","journal-title":"Front Neurol"},{"issue":"1","key":"4833_CR51","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A et al (2018) European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1\u2013G24. https:\/\/doi.org\/10.1530\/EJE-17-0796","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04833-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:03:46Z","timestamp":1735560226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04833-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04833-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author Adriana Ioachimescu receives research funding directed to the institution from Recordati and Chiesi. She also serves as an occasional consultant for Camurus, Crinetics, Recordati and Chiesi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed and written consent was obtained from the participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the case study and of the images in Fig.\u00a0\n                      \n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}